Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 13/20 | 0.51 |
| ▸ | CRBN | Q96SW2 | 13/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | OGFRL1 | Q5TC84 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 2/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.38 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29347426 | 0.95 | DDB1 (0.51) | DDB1CRBNOPRM1OPRD1OPRK1 | |
| SCHEMBL31730014 | 0.93 | DDB1 (0.50) | DDB1CRBNDRD2CNR2CAMK2D | |
| SCHEMBL31729996 | 0.91 | DDB1 (0.58) | DDB1CRBNOPRM1OPRD1OPRK1 | |
| SCHEMBL20850714 | 0.87 | DDB1 (0.63) | DDB1CRBN | |
| SCHEMBL31068515 | 0.84 | DDB1 (0.51) | DDB1CRBNOPRM1OPRL1 | |
| SCHEMBL29347429 | 0.83 | DDB1 (0.48) | DDB1CRBNOPRM1OPRL1 | |
| SCHEMBL29347124 | 0.83 | DDB1 (0.47) | DDB1CRBNOPRM1OPRL1 | |
| SCHEMBL31068572 | 0.82 | DDB1 (0.55) | DDB1CRBN | |
| SCHEMBL29346456 | 0.80 | DDB1 (0.60) | DDB1CRBNOPRM1OPRD1OPRK1 | |
| SCHEMBL31730022 | 0.79 | CRBN (0.50) | DDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4650348-A1 | CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR | Mitsubishi Tanabe Pharma Corporation (JP) | 2025-11-19 | — | — | EP | disclosed |
| WO-2024150815-A1 | CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR | 田辺三菱製薬株式会社 | 2024-07-18 | — | — | WO | disclosed |